Table I.
Group | D0 | Dq | SF2 |
---|---|---|---|
MDA-MB-435 | |||
Untreated | 2.093±0.131a | 2.088±0.046 | 0.574±0.018a |
siCTC1#3 | 1.475±0.153b | 1.472±0.095b | 0.417±0.016b |
siNC | 1.929±0.099 | 2.135±0.106 | 0.578±0.029 |
Mock | 1.993±0.164 | 2.258±0.094 | 0.595±0.017 |
MDA-MB-435R | |||
Untreated | 3.266±0.072 | 2.379±0.108 | 0.701±0.016 |
siCTC1#3 | 2.356±0.109c | 1.331±0.074c | 0.565±0.031c |
siNC | 3.153±0.156 | 2.247±0.089 | 0.677±0.014 |
Mock | 3.231±0.155 | 2.324±0.101 | 0.696±0.022 |
D0, Dq and SF2 values were calculated according to the survival curves. D0, the incremental dose required for reducing the fraction of colonies to 37%, indicative of single-event killing; Dq, quasi-threshold dose; SF2, the survival fraction of exponentially growing cells when irradiated at the clinically relevant dose of 2 Gy. Data are presented as the means ± SD of 3 independent experiments.
P<0.05 vs. untreated MDA-MB-435R cells;
P<0.05 and
P<0.05 vs. siNC and mock group, respectively. siNC groups showed no apparent differences with the mock groups.